Research Progress of CD19 CAR-T Cell Therapy_ACROBiosystems 한국 수입공급 전문 - 코아사이언스
안녕하세요!
표적 치료제, 진단, 백신 연구관련 시약 및 재조합단백질 전문 제조사 ACROBiosystems 공식 수입/공급 업체 코아사이언스 입니다.
자세한 상품 정보 및 관련 문의는 전화 02-858-0328 또는 info@coresciences.co.kr로 문의주시기 바랍니다.
감사합니다!
Research Progress of CD19 CAR-T Cell Therapy
Cell and gene therapy has become the next wave for mankind to fight cancer, and CAR-T cell therapy is one of the most promising tumor immunotherapies which has made a great progress in the treatment of various malignant tumors in recent years. Among them, CD19 is the most popular and successful target in the CAR-T therapy research, and there are many related drugs approved by FDA.
Approved CD19 CAR-T Drugs Information
ACROBiosystems has developed an extensive collection of reagents to support your CD19 CAR-T cell therapy development. These products are suitable for immunization, antibody screening, antibody affinity measurement and detection of anti-CD19 CAR expression.
CD19 Protein

★PE/FITC/APC/Alexa Fluor-488/555/647 labeled CD19 proteins are available
★High activity verified ELISA, SPR and FACS
★Suitable for detecting anti-CD19 CAR and antibody screening
Anti FMC63 scFv antibody

★Flow cytometry validated
★High specificity and sensitivity
★Evaluate CD19 CAR expression in clinical trials

추천 상품
[가스 투과성 세포 배양 백] NIPRO Cell Culture Bags [87-352, 87-302] & Connecting Tube [87-360]

코아사이언스 coresciences Acrobiosystems Acro biosystems 면역치료제 immuno cell therapy targeted therapy cytokines 사이토카인 recombinant proteins 재조합 단백질 인터페론 CART T cell B-cell natural killer cell 자연살상세포 항체 antibody 면역학 immunology